How it all started: tau and protein phosphatase 2A
- PMID: 23948891
- DOI: 10.3233/JAD-130503
How it all started: tau and protein phosphatase 2A
Abstract
This review is dedicated to Inge Grundke-Iqbal who laid the foundations of the tau field, by isolating tau from the Alzheimer's disease (AD) brain, discovering that tau is hyperphosphorylated, and proving a critical role of protein phosphatase 2A (PP2A) and its endogenous inhibitor I2PP2A in this process. This memorial starts with a few personal notes, and then covers how subcellular fractionation helped in isolating tau. We review in detail the role of PP2A and its endogenous inhibitor in tau phosphorylation. We discuss the role that methylation and phosphorylation have in regulating PP2A activity. We add what we have contributed to understanding the role of tau and PP2A in AD using PP2A transgenic and knockout models, and conclude by addressing two underexplored areas in tau research: tau's non-canonical functions and the role distinct tau isoforms have in a physiological context.
Similar articles
-
Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.Neurobiol Dis. 2008 Sep;31(3):386-94. doi: 10.1016/j.nbd.2008.05.013. Epub 2008 Jul 23. Neurobiol Dis. 2008. PMID: 18586097
-
Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau.FEBS Lett. 2005 Jan 17;579(2):363-72. doi: 10.1016/j.febslet.2004.11.097. FEBS Lett. 2005. PMID: 15642345
-
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.J Clin Neurosci. 2010 Aug;17(8):1025-33. doi: 10.1016/j.jocn.2010.04.020. Epub 2010 May 26. J Clin Neurosci. 2010. PMID: 20537899
-
Animal models of the sporadic form of Alzheimer's disease: focus on the disease and not just the lesions.J Alzheimers Dis. 2013;37(3):469-74. doi: 10.3233/JAD-130827. J Alzheimers Dis. 2013. PMID: 23948903 Review.
-
Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A.Ageing Res Rev. 2013 Jan;12(1):39-49. doi: 10.1016/j.arr.2012.06.008. Epub 2012 Jul 6. Ageing Res Rev. 2013. PMID: 22771380 Review.
Cited by
-
RAR-Dependent and RAR-Independent RXR Signaling in Stem-like Glioma Cells.Int J Mol Sci. 2023 Nov 17;24(22):16466. doi: 10.3390/ijms242216466. Int J Mol Sci. 2023. PMID: 38003656 Free PMC article.
-
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities.Transl Neurodegener. 2020 Jan 6;9:1. doi: 10.1186/s40035-019-0179-3. eCollection 2020. Transl Neurodegener. 2020. PMID: 31911834 Free PMC article. Review.
-
The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons.Int J Mol Sci. 2019 Feb 15;20(4):844. doi: 10.3390/ijms20040844. Int J Mol Sci. 2019. PMID: 30781361 Free PMC article.
-
Age-related p53 SUMOylation accelerates senescence and tau pathology in Alzheimer's disease.Cell Death Differ. 2025 May;32(5):837-854. doi: 10.1038/s41418-025-01448-0. Epub 2025 Jan 28. Cell Death Differ. 2025. PMID: 39870805
-
Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer's disease.Front Aging Neurosci. 2022 Sep 29;14:1014305. doi: 10.3389/fnagi.2022.1014305. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36247998 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical